Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Insights into Imaging
Published in: Insights into Imaging 1/2019

Open Access 01-12-2019 | Idiopathic Pulmonary Fibrosis | Educational Review

Diffuse smoking-related lung diseases: insights from a radiologic-pathologic correlation

Authors: Célia Sousa, Márcio Rodrigues, André Carvalho, Bárbara Viamonte, Rui Cunha, Susana Guimarães, Conceição Souto de Moura, António Morais, José Miguel Pereira

Published in: Insights into Imaging | Issue 1/2019

Login to get access

Abstract

Cigarettes are well-recognized risk factors responsible for the emergence of a variety of pathologic conditions affecting both the airways and the lungs. Smoking-related lung diseases can be classified as chronic obstructive pulmonary disease (COPD) and several types of interstitial diseases, such as pulmonary Langerhans cell histiocytosis, bronchiolitis, desquamative interstitial pneumonitis, acute eosinophilic pneumonia, and interstitial fibrosing lung diseases. The evidence of combined lower lung fibrosis and predominant upper lung emphysema is renowned as a distinct clinical entity, named combined pulmonary fibrosis and emphysema. Although computerized tomography permits an adequate classification and distinction of these diseases, the clinical, imaging, and histological features often overlap and coexist in a single patient. Therefore, a combined radiologic and pathologic approach, in the appropriate clinical setting, is useful for best comprehension and distinction of these entities. Our goals are to describe the imaging features in smoking-related lung diseases and how the pathological manifestations translate on high-resolution computerized tomography.
Literature
1.
2.
Fowles J, Dybing E (2003) Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke. Tob Control. 12:424–430PubMedPubMedCentralCrossRef
3.
Celli BR, MacNee W, Force AET (2004) Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 23:932–946PubMedCrossRef
4.
Ezzati M, Lopez AD (2003) Estimates of global mortality attributable to smoking in 2000. Lancet. 362:847–852PubMedCrossRef
5.
Konopka KE, Myers JL (2018) A review of smoking-related interstitial fibrosis, respiratory bronchiolitis, and desquamative interstitial pneumonia: overlapping histology and confusing terminology. Arch Pathol Lab Med. 142(10):1177–1118PubMedCrossRef
6.
Walsh SL, Nair A, Desai SR (2015) Interstitial lung disease related to smoking: imaging considerations. Curr Opin Pulm Med. 21:407–416PubMedCrossRef
7.
8.
Viegi G, Pistelli F, Sherrill DL et al (2007) Definition, epidemiology and natural history of COPD. Eur Respir J. 30(5):993–1013PubMedCrossRef
9.
The definition of emphysema (1985) Report of a National Heart, Lung, and Blood Institute, Division of Lung Diseases workshop. Am Rev Respir Dis 132:182–185
10.
Smith BM, Austin JH, Newell JD Jr et al (2014) Pulmonary emphysema subtypes on computed tomography: the MESA COPD study. Am J Med 127(1):94.e7–94e23CrossRef
11.
McDonough JE, Yuan R, Suzuki M et al (2011) Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med. 365(17):1567–1575PubMedPubMedCentralCrossRef
12.
Diaz AA, Valim C, Yamashiro T et al (2010) Airway count and emphysema assessed by chest CT imaging predicts clinical outcome in smokers. Chest. 138:880–887PubMedPubMedCentralCrossRef
13.
Kuwano K, Matsuba K, Ikeda T et al (1990) The diagnosis of mild emphysema. Correlation of computed tomography and pathology scores. Am Rev Respir Dis. 141:169–178PubMedCrossRef
14.
Spouge D, Mayo JR, Cardoso W et al (1993) Panacinar emphysema: CT and pathologic findings. J Comput Assist Tomogr. 17:710–713PubMedCrossRef
15.
MacNee W, Tuder RM (2009) New paradigms in the pathogenesis of chronic obstructive pulmonary disease I. Proc Am Thorac Soc. 6(6):527–531PubMedCrossRef
16.
17.
Vestbo J, Prescott E, Lange P (1996) Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am J Respir Crit Care Med. 153:1530–1535PubMedCrossRef
18.
Guerra S, Sherrill DL, Venker C et al (2009) Chronic bronchitis before age 50 years predicts incident airflow limitation and mortality risk. Thorax. 64:894–900PubMedCrossRef
19.
Sherman CB, Xu X, Speizer FE et al (1992) Longitudinal lung function decline in subjects with respiratory symptoms. Am Rev Respir Dis. 146:855–859PubMedCrossRef
20.
Lynch DA, Austin JH, Hogg JC et al (2015) CT-definable subtypes of chronic obstructive pulmonary disease: a statement of the Fleischner Society. Radiology. 277(1):192–205PubMedCrossRef
21.
Stoller JK, Aboussouan LS (2012) A review of alpha1-antitrypsin deficiency. Am J Respir Crit Care Med. 185:246–259PubMedCrossRef
22.
De Giacomi F, Vassallo R, Yi ES et al (2018) Acute eosinophilic pneumonia: causes, diagnosis and management. Am J Respir Crit Care Med. 197(6):728–736PubMedCrossRef
23.
24.
Kligerman S, Franks T, Galvin J (2016) Clinical-radiologic-pathologic correlation of smoking-related diffuse parenchymal lung disease. Radiol Clin North Am. 54(6):1047–1063PubMedCrossRef
25.
Cottin V, Cordier JF (2012) Eosinophilic lung diseases. Immunol Allergy Clin N Am. 32(4):557–586CrossRef
26.
Uchiyama H, Suda T, Nakamura Y et al (2008) Alterations in smoking habits are associated with acute eosinophilic pneumonia. Chest. 133(5):1174–1180PubMedCrossRef
27.
Philit F, Etienne-Mastroianni B, Parrot A et al (2002) Idiopathic acute eosinophilic pneumonia: a study of 22 patients. Am J Respir Crit Care Med. 166:1235–1239PubMedCrossRef
28.
Shorr AF, Scoville SL, Cersovsky SB et al (2004) Acute eosinophilic pneumonia among US military personnel deployed in or near Iraq. JAMA. 292:2997–3005PubMedCrossRef
29.
30.
Attili AK, Kazerooni EA, Gross BH et al (2008) Smoking-related interstitial lung disease: radiologic–clinical–pathologic correlation. Radiographics. 28:1383–1396PubMedCrossRef
31.
Bano S, Chaudhary V, Narula MK et al (2014) Pulmonary Langerhans cell histiocytosis in children: a spectrum of radiologic findings. Eur J Radiol. 83(1):47–56PubMedCrossRef
32.
Radzikowska E (2017) Pulmonary Langerhans’ cell histiocytosis in adults. Adv Respir Med. 85:277–289PubMedCrossRef
33.
Vassallo R, Harari S, Tazi A (2017) Current understanding and management of pulmonary Langerhans cell histiocytosis. Thorax. 72(10):937–945PubMedCrossRef
34.
Girschikofsky M, Arico M, Castillo D et al (2013) Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-Net. Orphanet J Rare Dis. 8:72PubMedPubMedCentralCrossRef
35.
Harari S, Torre O, Cassandro R et al (2012) Bronchoscopic diagnosis of Langerhans cell histiocytosis and lymphangioleiomyomatosis. Respir Med. 106(9):1286–1292PubMedPubMedCentralCrossRef
36.
Picarsic J, Jaffe R (2015) Nosology and pathology of Langerhans cell histiocytosis. Hematol Oncol Clin North Am. 29:799–823PubMedCrossRef
37.
38.
Rao RN, Goodman LR, Tomashefski JF Jr (2008) Smoking-related interstitial lung disease. Ann Diagn Pathol. 12:445–457PubMedCrossRef
39.
40.
Tazi A, de Margerie C, Naccache JM et al (2015) The natural history of adult pulmonary Langerhans cell histiocytosis: a prospective multicentre study. Orphanet J Rare Dis.
41.
42.
Vassallo R, Ryu JH, Schroeder DR et al (2002) Clinical outcomes of pulmonary Langerhans’-cell histiocytosis in adults. N Engl J Med. 346(7):484–490PubMedCrossRef
43.
Stockschlaeder M, Sucker C (2006) Adult Langerhans cell histiocytosis. Eur J Haematol. 76(5):363–368PubMedCrossRef
44.
Elia D, Torre O, Cassandro R et al (2015) Pulmonary Langerhans cell histiocytosis: a comprehensive analysis of 40 patients and literature review. Eur J Intern Med. 26(5):351–356PubMedCrossRef
45.
Schönfeld N, Dirks K, Costabel U et al (2012) A prospective clinical multicentre study on adult pulmonary Langerhans’ cell histiocytosis. Sarcoidosis Vasc Diffuse Lung Dis. 29(2):132–138PubMed
46.
Negrin-Dastis S, Butenda D, Dorzee J et al (2007) Complete disappearance of lung abnormalities on high-resolution computed tomography: a case of histiocytosis X. Can Respir J. 14(4):235–237PubMedPubMedCentralCrossRef
47.
Tazi A, Marc K, Dominique S et al (2012) Serial computed tomography and lung function testing in pulmonary Langerhans’ cell histiocytosis. Eur Respir J. 40:905–912PubMedCrossRef
48.
Castoldi MC, Verrioli A, De Juli E et al (2014) Pulmonary Langerhans cell histiocytosis: the many faces of presentation at initial CT scan. Insights Imaging. 5:483–492PubMedPubMedCentralCrossRef
49.
Richards JC, Lynch DA, Chung JH (2015) Cystic and nodular lung disease. Clin Chest Med. 36:299–312PubMedCrossRef
50.
Madan R, Matalon S, Vivero M (2016) Spectrum of smoking-related lung diseases: imaging review and update. J Thorac Imaging. 31(2):78–91PubMedCrossRef
51.
Ryu JH, Myers JL, Capizzi SA, Douglas WW, Vassallo R, Decker PA (2005) Desquamative interstitial pneumonia and respiratory bronchiolitis-associated interstitial lung disease. Chest. 127:178–184PubMedCrossRef
52.
Moon J, du Bois RM, Colby TV et al (1999) Clinical significance of respiratory bronchiolitis on open lung biopsy and its relationship to smoking related interstitial lung disease. Thorax. 54:1009–1014PubMedPubMedCentralCrossRef
53.
King TE Jr (1993) Respiratory bronchiolitis-associated interstitial lung disease. Clin Chest Med. 14:693–698PubMed
54.
Park JS, Brown KK, Tuder RM et al (2002) Respiratory bronchiolitis-associated interstitial lung disease: radiologic features with clinical and pathologic correlation. J Comput Assist Tomogr l26:13–20CrossRef
55.
Craig PJ, Wells AU, Doffman S et al (2004) Desquamative interstitial pneumonia, respiratory bronchiolitis and their relationship to smoking. Histopathology. 45(3):275–282PubMedCrossRef
56.
Liebow AA, Steer A, Billingsley JG (1965) Desquamative interstitial pneumonia. Am J Med. 39:369–404PubMedCrossRef
57.
Reddy TL, Mayo J, Churg A (2013) Respiratory bronchiolitis with fibrosis: high resolution computed tomography findings and correlation with pathology. Ann Am Thorac Soc. 10(6):590–601PubMedCrossRef
58.
Katzenstein AL (2012) Smoking-related interstitial fibrosis (SRIF), pathogenesis and treatment of usual interstitial pneumonia (UIP), and transbronchial biopsy in UIP. Mod Pathol. 25(Suppl 1):S68–S78PubMedCrossRef
59.
Katzenstein AL (2013) Smoking-related interstitial fibrosis (SRIF): pathologic findings and distinction from other chronic fibrosing lung diseases. J Clin Pathol. 66(10):882–887PubMedCrossRef
60.
Katzenstein AL, Mukhopadhay S, Zanardi C, Dexter E (2010) Clinically occult interstitial fibrosis in smokers: classification and significance of a surprisingly common finding in lobectomy specimens. Hum Pathol. 41(3):316–325PubMedCrossRef
61.
Yousem SA (2006) Respiratory bronchiolitis-associated interstitial lung disease with fibrosis is a lesion distinct from fibrotic nonspecific interstitial pneumonia: a proposal. Mod Pathol. 19(11):1474–1479PubMedCrossRef
62.
Kawabata Y, Hoshi E, Murai K et al (2008) Smoking-related changes in the background lung specimens resected for lung cancer: a semiquantitative study with correlation to postoperative course. Histopathology. 53(6):707–714PubMedCrossRef
63.
Yamada T, Nakanishi Y, Homma T et al (2013) Airspace enlargement with fibrosis shows characteristic histology and immunohistology different from usual interstitial pneumonia, nonspecific interstitial pneumonia and centrilobular emphysema. Pathol Int. 63(4):206–213PubMedCrossRef
64.
Watanabe Y, Kawabata Y, Kanauchi T et al (2015) Multiple, thin-walled cysts are one of the HRCT features of airspace enlargement with fibrosis. Eur J Radiol. 84(5):986–992PubMedCrossRef
65.
Franks TJ, Galvin JR (2015) Smoking-related “interstitial” lung disease. Arch Pathol Lab Med. 139(8):974–977PubMedCrossRef
66.
67.
Raghu G, Collard HR, Egan JJ et al (2011) An official ATS/ERS/ JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 183:788–824PubMedPubMedCentralCrossRef
68.
Baumgartner KB, Samet JM, Stidley CA et al (1997) Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 155:242–248PubMedCrossRef
69.
Ley B, Collard HR, King TE (2011) Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 183:43140CrossRef
70.
71.
Antoniou KM, Hansell DM, Rubens MB et al (2008) Idiopathic pulmonary fibrosis: outcome in relation to smoking status. Am J Respir Crit Care Med. 177:190–194PubMedCrossRef
72.
Lynch DA, Sverzellati N, Travis WD et al (2018) Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper. Lancet Respir Med. 6(2):138–153PubMedCrossRef
73.
Kitaguchi Y, Fujimoto K, Hanaoka M et al (2010) Clinical characteristics of combined pulmonary fibrosis and emphysema. Respirology. 15:265–271PubMedCrossRef
74.
Grubstein A, Bendayan D, Schactman I et al (2005) Concomitant upper-lobe bullous emphysema, lower-lobe interstitial fibrosis and pulmonary hypertension in heavy smokers: report of eight cases and review of the literature. Respir Med. 99:948–954PubMedCrossRef
75.
Mura M, Zompatori M, Pacilli AM et al (2006) The presence of emphysema further impairs physiologic function in patients with idiopathic pulmonary fibrosis. Respir Care. 51:257–265PubMed
76.
Jankowich MD, Polsky M, Klein M et al (2008) Heterogeneity in combined pulmonary fibrosis and emphysema. Respiration. 75:411–417PubMedCrossRef
77.
Cottin V, Cordier JF (2009) The syndrome of combined pulmonary fibrosis and emphysema. Chest. 136(1):1–2PubMedCrossRef
78.
Mitchell PD, Das JP, Murphy DJ et al (2015) Idiopathic pulmonary fibrosis with emphysema: evidence of synergy among emphysema and idiopathic pulmonary fibrosis in smokers. Respir Care. 60:259–268PubMedCrossRef
79.
Zhang L, Zhang C, Dong F et al (2016) Combined pulmonary fibrosis and emphysema: a retrospective analysis of clinical characteristics, treatment and prognosis. BMC Pulm Med. 16:137PubMedPubMedCentralCrossRef
80.
Ryerson CJ, Hartman T, Elicker BM et al (2013) Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis. Chest. 144(1):234–240PubMedCrossRef
81.
Cottin V, Nunes H, Brillet PY et al (2005) Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J. 26:586–593PubMedCrossRef
82.
Mejía M, Carrillo G, Rojas-Serrano J et al (2009) Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension. Chest. 136:10–15PubMedCrossRef
83.
Cottin V, Le Pavec J, Prévot G et al (2010) Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur Respir J. 35:105–111PubMedCrossRef
84.
Usui K, Tanai C, Tanaka Y et al (2011) The prevalence of pulmonary fibrosis combined with emphysema in patients with lung cancer. Respirology. 16:326–331PubMedCrossRef
85.
Matsuoka S, Yamashiro T, Matsushita S et al (2015) Morphological disease progression of combined pulmonary fibrosis and emphysema: comparison with emphysema alone and pulmonary fibrosis alone. J Comput Assist Tomogr. 39:153–159PubMedCrossRef
86.
Metadata
Title
Diffuse smoking-related lung diseases: insights from a radiologic-pathologic correlation
Authors
Célia Sousa
Márcio Rodrigues
André Carvalho
Bárbara Viamonte
Rui Cunha
Susana Guimarães
Conceição Souto de Moura
António Morais
José Miguel Pereira
Publication date
01-12-2019
Publisher
Springer Berlin Heidelberg
Published in
Insights into Imaging / Issue 1/2019
Electronic ISSN: 1869-4101
DOI
https://doi.org/10.1186/s13244-019-0765-z

Other articles of this Issue 1/2019

Insights into Imaging 1/2019 Go to the issue

Educational Review

Imaging of brown tumours: a pictorial review

Pictorial Review

Pathophysiology of right ventricular failure in acute pulmonary embolism and chronic thromboembolic pulmonary hypertension: a pictorial essay for the interventional radiologist

Review

Thyroglossal duct pathology and mimics

Educational Review

Perinatal post-mortem ultrasound (PMUS): radiological-pathological correlation

Educational Review

A radiologic review of hoarse voice from anatomic and neurologic perspectives

Educational Review

Brain MR findings in patients treated with particle therapy for skull base tumors